Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05939570 · ClinicalTrials.gov registry record
DOSC and Association With Neighborhood Opportunity: Phase II
A clinical trial of Pediatric Day of Surgery Cancellations, sponsored by Nationwide Children's Hospital.
- Recruiting
- Registry status
- 30
- Enrollment target
- 1
- Study location
NCT05939570: Recruiting study of Pediatric Day of Surgery Cancellations, sponsored by Nationwide Children's Hospital.
NCT05939570 is a study of Pediatric Day of Surgery Cancellations that is actively recruiting participants, run by Nationwide Children's Hospital. The registered enrollment target is 30 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05939570, a study of Pediatric Day of Surgery Cancellations, is actively recruiting participants, sponsored by Nationwide Children's Hospital.
- RECRUITING
- Registry status
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
Prospective, qualitative interview study to explore factors associated with pediatric day of surgery cancellations (DOSC) from the prospective of parents with hopes the interviews will reveal additional vulnerabilities not included in COI 2.0 that predispose to DOSC.
Conditions Studied
Interventions
- OTHER Interview
Study Locations (1)
Ohio
- Nationwide Children's Hospital - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2023-07-25 |
| Est. Completion | 2025-12 |
What NCT05939570 shows while recruiting
NCT05939570 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 1 condition, with Pediatric Day of Surgery Cancellations appearing as the primary indexed condition, and to 1 intervention - of which Interview is the first listed.
NCT05939570 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT05939570 about?
NCT05939570 is a clinical study titled "DOSC and Association With Neighborhood Opportunity: Phase II". Prospective, qualitative interview study to explore factors associated with pediatric day of surgery cancellations (DOSC) from the prospective of parents with hopes the interviews will reveal additional vulnerabilities not included in COI 2.0 that predispose to DOSC.
What is the current status of trial NCT05939570?
This trial is currently recruiting. The enrollment target is 30 participants. The study started on 2023-07-25. Estimated completion is 2025-12.
What conditions does trial NCT05939570 study?
This clinical trial studies the following conditions: Pediatric Day of Surgery Cancellations.
What interventions are being tested in trial NCT05939570?
The interventions under investigation include: Interview (OTHER).
Who is sponsoring clinical trial NCT05939570?
This trial is sponsored by Nationwide Children's Hospital, which has 188 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05939570 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI